Revenio Group Oyj
HEL: REG1V.HE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Helsinki
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Jouni Toijala
- Employees
- 246
- Headquarters
- Vantaa, Finland
- IPO year
- 2001
- Market cap
- €369.3M
- Website
- https://www.reveniogroup.fi
Loading REG1V…
Loading profile data…Frequently asked questions about REG1V
What does Revenio Group Oyj (REG1V.HE) do?
Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics and devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measuremen...
Where does REG1V.HE trade?
Revenio Group Oyj (REG1V.HE) trades on the NASDAQ Helsinki.
What sector is REG1V.HE in?
Revenio Group Oyj (REG1V.HE) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Revenio Group Oyj?
Jouni Toijala is the chief executive officer of Revenio Group Oyj (REG1V.HE).
Where is Revenio Group Oyj headquartered?
Revenio Group Oyj is headquartered in Finland.
Does REG1V.HE pay a dividend?
Yes — Revenio Group Oyj (REG1V.HE) paid a trailing twelve-month dividend of EUR 0.40 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did REG1V.HE go public?
Revenio Group Oyj (REG1V.HE) completed its initial public offering in 2001.